Matrixlaboratorieslimitted
Records under this name other than patents Matrixlaboratorieslimitted holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Matrixlaboratorieslimitted
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,258,312 | Process for preparing pure valsartan Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,247,568 | Process for the preparation of pure rabeprazole Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,781,585 | Crystalline forms of Gatifloxacin Formerly held In force Term ended Sep 24, 2026 · From the USPTO record | In force | Term ended Sep 24, 2026 | From the USPTO record |
| US 8,530,647 | Process for the preparation of oxcarbazepine Formerly held Lapsed on the fee record Ended Sep 10, 2025 · From the USPTO record | Lapsed on the fee record | Ended Sep 10, 2025 | From the USPTO record |
| US 8,686,161 | Polymorphic forms of perindopril (L)-arginine and process for the preparation thereof Formerly held Lapsed on the fee record Ended Apr 1, 2022 · From the USPTO record | Lapsed on the fee record | Ended Apr 1, 2022 | From the USPTO record |